12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Biosimilar rituximab: Phase III start

Celltrion said it plans to start a Phase III trial of CT-P10 in 2H13. Celltrion had planned to conduct Phase I and Phase III testing simultaneously, but decided to run the trials sequentially after receiving advice from regulatory agencies. Celltrion said ongoing Phase I trials for cancer and autoimmune indications...

Read the full 226 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >